Post-traumatic stress disorder symptom improvement lasting years after MDMA-assisted psychotherapy. Principal Investigator Dr. Michael Mithoefer talks about the treatment approach and factors influencing the treatment response.
Author: Ilsa Jerome, PhD
I am Dr. Lisa “Ilsa” Jerome, a Medical Coder & Data Analyst at MAPS Public Benefit Corporation. My focus is on archiving, communicating and sharing information about studies into the effects, risks and benefits of MAPS’ primary study drugs, particularly MDMA and classic psychedelics. I am fascinated by sound and music, and fragrance and olfaction. I spent a couple of years as a DJ at a university radio station, and still enjoy making playlists from a wide variety of musical genres. Follow me on Spotify.
A Journey in Sound: Music in Psychedelic Assisted Psychotherapy
